Advertisement

Topics

Mars, Incorporated Completes Acquisition of VCA Inc.

05:36 EDT 12 Sep 2017 | PR Newswire

MCLEAN, Va. and LOS ANGELES, Sept. 12, 2017 /PRNewswire/ -- Mars, Incorporated and VCA Inc. (NASDAQ: WOOF) today announced the successful completion of Mars' previously announced acquisition of VCA. On January 9, 2017, Mars and VCA announced that they had entered into an agreement for Mars to acquire VCA for $93 per share in a transaction valued at approximately $9.1 billion. VCA will operate as a distinct and separate business within Mars Petcare, alongside its other veterinary services businesses, BANFIELD® Pet Hospital, BLUEPEARL® and PET PARTNERS™. VCA will continue to be led by Bob Antin, a co-founder of VCA, as Chief Executive Officer, and will remain headquartered in Los Angeles, California.

"I want to welcome the 25,000+ VCA team members to the Mars Petcare family of companies," said Mars Global Petcare President Poul Weihrauch. "This is a great day for all of us as we take a significant step forward in providing quality care and health services for thousands of more pets. VCA's partnerships with veterinarians and pet care providers, as well as their breadth and expertise in veterinary services, diagnostics and technology, will position all of us to deliver more comprehensive care and continue on our journey supporting our Purpose: A BETTER WORLD FOR PETS™."

Advisors

Morgan Stanley & Co. LLC and BDT & Co. are Mars' financial advisors. Skadden, Arps, Slate, Meagher & Flom is serving as Mars' legal advisor with Simpson Thacher & Bartlett providing legal advice for the debt financing.

Barclays was the exclusive financial advisor to VCA and Akin Gump Strauss Hauer & Feld LLP served as VCA's legal advisor.

J.P. Morgan & Co provided financing to Mars for the transaction.

About Mars, Incorporated

Mars is a family-owned business with more than a century of history making diverse products and offering services for people and the pets people love. With almost $35 billion in sales, the company is a global business that produces some of the world's best-loved brands: M&M's®, SNICKERS®, TWIX®, MILKY WAY®, DOVE®, PEDIGREE®, ROYAL CANIN®, WHISKAS®, EXTRA®, ORBIT®, 5™, SKITTLES®, UNCLE BEN'S®, MARS DRINKS and COCOAVIA®. Mars also provides veterinary health services that include BANFIELD® Pet Hospitals, BLUEPEARL® Specialty and Emergency Pet Hospitals and PET PARTNERS™ Veterinary Hospitals. Headquartered in McLean, VA, Mars operates in more than 80 countries. The Mars Five Principles – Quality, Responsibility, Mutuality, Efficiency and Freedom – inspire its more than 85,000 Associates to create value for all its partners and deliver growth they are proud of every day.

For more information about Mars, please visit. Join us on Facebook, Twitter, LinkedIn, Instagram and YouTube.

About VCA Inc.

VCA is a leading provider of pet health care services in the country delivered through over 800 small animal veterinary hospitals in the US and Canada, a preeminent nationwide clinical laboratory system that services all 50 states and Canada (Antech Diagnostics), the leading animal diagnostic imaging company in the market (Sound), and Camp Bow Wow (CBW), the nation's Premier Doggy Day and Overnight Camp® franchise.

Media Contacts

Mars, Incorporated  
Brunswick Group 
Blake Sonnenshein 
(212) 333-3810

VCA Inc. 
Tomas W. Fuller 
Chief Financial Officer 
(310) 571-6505

View original content:http://www.prnewswire.com/news-releases/mars-incorporated-completes-acquisition-of-vca-inc-300517872.html

SOURCE Mars, Incorporated and VCA Inc.

NEXT ARTICLE

More From BioPortfolio on "Mars, Incorporated Completes Acquisition of VCA Inc."

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...